We are live on
!
Find out more
EMR
Errol M. Rudman Portfolio holdings
AUM
$148M
1-Year Est. Return
19.65%
This Fund
S&P 500
This Quarter
Est. Return
+6.94%
1 Year Est. Return
+19.65%
3 Year Est. Return
+60.53%
5 Year Est. Return
+120.34%
10 Year Est. Return
–
AUM
$199M
AUM Growth
+$43.7M
(+28%)
Cap. Flow
+$33.5M
Cap. Flow
% of AUM
16.82%
Top 10 Holdings %
Top 10 Hldgs %
59.34%
Holding
42
New
12
Increased
12
Reduced
6
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TransDigm Group
TDG
|
+$6.24M |
| 2 |
iShares Biotechnology ETF
IBB
|
+$4.43M |
| 3 |
State Street SPDR S&P Biotech ETF
XBI
|
+$4.26M |
| 4 |
Floor & Decor
FND
|
+$1.97M |
| 5 |
McKesson
MCK
|
+$1.82M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LVLT
Level 3 Communications Inc
LVLT
|
+$602K |
| 2 |
Thermo Fisher Scientific
TMO
|
+$185K |
| 3 |
CVS Health
CVS
|
+$130K |
| 4 |
HCA Healthcare
HCA
|
+$118K |
| 5 |
CBPO
China Biologic Products Holdings, Inc.
CBPO
|
+$83.8K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 37.17% |
| 2 | Healthcare | 23.07% |
| 3 | Consumer Discretionary | 12.56% |
| 4 | Financials | 8.6% |
| 5 | Miscellaneous | 8.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Floor & Decor
FND
$5.68B
| $1.98M | 1% |
+50,500
| New | +$1.97M |
|
27
Tenet Healthcare
THC
$21.6B
| $1.93M | 0.97% |
100,000
+50,000
| +100% | +$872K |
|
|
SEE
28
DELISTED
Sealed Air
SEE
| $1.79M | 0.9% |
+40,000
| New | +$1.76M |
|
29
American Airlines Group
AAL
$9.08B
| $1.7M | 0.85% |
33,720
+10,000
| +42% | +$465K |
|
30
Entegris
ENTG
$22.2B
| $1.7M | 0.85% |
77,291
| – | – |
|
|
31
Thermo Fisher Scientific
TMO
$233B
| $1.45M | 0.73% |
8,300
-1,100
| -12% | -$185K |
|
32
ASML
ASML
$666B
| $1.3M | 0.65% |
+10,000
| New | +$1.32M |
|
33
Cognex
CGNX
$10.6B
| $1.27M | 0.64% |
+30,000
| New | +$1.33M |
|
34
ProShares Ultra Gold
UGL
$912M
| $1.19M | 0.6% |
126,000
+6,000
| +5% | +$58.4K |
|
35
Citigroup
C
$223B
| $1M | 0.5% |
+15,000
| New | +$920K |
|
36
JPMorgan Chase
JPM
$942B
| $914K | 0.46% |
+10,000
| New | +$863K |
|
37
Wells Fargo
WFC
$257B
| $831K | 0.42% |
+15,000
| New | +$804K |
|
38
US Foods
USFD
$23.3B
| $817K | 0.41% |
+30,000
| New | +$854K |
|
39
GE Aerospace
GE
$356B
| $650K | 0.33% |
5,018
| – | – |
|
40
Lumen
LUMN
$6.33B
| $478K | 0.24% |
+20,000
| New | +$502K |
|
|
CCRN
41
DELISTED
Cross Country Healthcare
CCRN
| $443K | 0.22% |
34,282
-5,356
| -14% | -$69K |
|
42
Bank of America
BAC
$428B
| $364K | 0.18% |
+15,000
| New | +$350K |
|
Similar funds
HAM
TAM
RMPT
QAM
CWM
RCA
CI
LS
Errol M. Rudman's Q2 2017 Portfolio in Review
As of Q2 2017, Errol M. Rudman held 42 positions worth $199M, up 28% from $155M the previous quarter. Its ten largest holdings account for 59% of the portfolio.
Errol M. Rudman deployed $33.5M of net new capital in Q2 2017, opening 12 new positions and adding to 12 existing holdings. Its largest new stake was iShares Biotechnology ETF: 45,000 shares worth $4.65M.
By sector, the portfolio is most concentrated in Industrials at 37% of assets, down from 39% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Level 3 Communications Inc, an estimated $602K trimmed.
- Errol M. Rudman's largest Q2 2017 buy was iShares Biotechnology ETF: 45,000 shares worth $4.65M.
- Errol M. Rudman added most to TransDigm Group in Q2 2017, an estimated $6.24M increase.
- Errol M. Rudman's biggest Q2 2017 reduction was Level 3 Communications Inc, cutting an estimated $602K.
- Errol M. Rudman's ten largest holdings make up 59% of its $199M portfolio in Q2 2017.
- Errol M. Rudman opened 12 new positions and closed 0 in Q2 2017.
- Errol M. Rudman's portfolio value rose 28% quarter-over-quarter to $199M.
Based on Errol M. Rudman's 13F filing for Q2 2017, filed 14 Aug 2017.